Alan Keller to Doxorubicin
This is a "connection" page, showing publications Alan Keller has written about Doxorubicin.
Connection Strength
0.226
-
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer. J Clin Oncol. 2004 Oct 01; 22(19):3893-901.
Score: 0.226